Disc Medicine
Disc Medicine is a biopharmaceutical company dedicated to transforming the lives of patients with hematologic disorders.
89 employees · est. 2017 · Watertown, United States
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
389 employees · est. 2008 · Rockville, United States
REGENXBIO is the older company (2017 vs 2008); REGENXBIO is the larger of the two.
Side-by-Side Comparison
| Metric | Disc Medicine | REGENXBIO |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2008 older |
| Headquarters | ||
| Headquarters | Watertown, United States | Rockville, United States |
| Employees | ||
| Employees | 89 | 389 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $592.80M | $1.58B |
| Funding Rounds | ||
| Funding Rounds | 6 | 17 |
| Services | ||
| Services | Not tracked yet | Developing Gene Therapy Candidates, Clinical Trials, In-house Manufacturing, Research and Development |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Retinal Diseases, Patients with Genetic Disorders, Healthcare Providers, Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Hematologic Disorders, Therapeutic Candidates, Red Blood Cell Biology, Hematologic Diseases, Rare Blood Disorders, Scientific Leadership, Industry Expertise, Advisory Panel, Drug Development, Atlas Venture, Novo Ventures, Access Biotechnology, Innovation, Life Sciences | Gene Therapy, AAV Therapeutics, Biopharmaceuticals, Retinal Diseases, Rare Diseases, AAV Vectors, Metabolic Disorders, Muscle Diseases, Hematologic Disorders, Ocular Diseases, Neurodegenerative Disorders, One-time Treatments, Therapeutic Development, Reagent Services |
| Website | ||
| Website | discmedicine.com | regenxbio.com |
About Disc Medicine
Disc Medicine is a biopharmaceutical company founded in 2017 and based in the United States, with a focus on revolutionizing the treatment landscape for patients with hematologic disorders. Their commitment to making a difference in patients' lives is encapsulated in their slogan: "Disc Medicine is...
About REGENXBIO
REGENXBIO, founded in 2008, is a clinical-stage biotechnology company based in the United States known for its pioneering work in AAV Therapeutics, a promising class of gene therapy medicines. The company is actively advancing a robust pipeline targeting retinal and rare diseases with products like...
We will tell you when either one moves
BounceWatch watches Disc Medicine and REGENXBIO for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Disc Medicine and REGENXBIO — by email.
Frequently Asked Questions
Compare Disc Medicine with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Disc Medicine on 12 Sep 2024, and REGENXBIO on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
